Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis

Abstract

Angiogenesis, the formation of new blood vessels, is required for normal tissue development and pathological conditions such as tumorigenesis. Most solid tumors can not grow beyond a few millimeters without the recruitment of neovessels since cancer cells require access to blood vessels for nutrients and to escape the local environment and metastasize to other tissue and organ sites. Targeting tumor vessel endothelium therefore should serve as an effective therapy for cancers. Maspin is a serpin that exhibits antiangiogenic properties. In this report, we show that when maspin overexpression is targeted in vivo to endothelial cells, it actively induces endothelial cell apoptosis. Intravascular administration of adenovirus-maspin to mice bearing mammary tumors disrupts tumor-induced angiogenesis. Interestingly, tumor neovessels become leaky after maspin treatment, whereas normal mature vessels are not affected by maspin treatment. We further demonstrate that maspin directly induces endothelial cell apoptosis in vitro, and this effect is maspin specific. The induction of apoptosis is accompanied by changes in the expression of Bcl-2 family genes and is blocked by caspase inhibitors. In addition, the apoptotic effect is mediated by intracellular maspin and is dependent on the RSL region of maspin. Furthermore, we have shown that transient overexpression of Bcl-2 protected the HUVECs from maspin-mediated apoptosis, and the presence of both maspin and Bax accelerated the apoptosis process. These findings demonstrate that neovascular endothelial cells are highly sensitive to maspin level inside the cells. This property can be used for targeted therapy against tumor angiogenesis and metastasis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Bird CH, Sutton VR, Sun J, Hirst CE, Novak A, Kumar S, Trapani JA and Bird PI . (1998). Mol. Cell. Biol., 18, 6387–6398.

  • Budihardjo I, Oliver H, Lutter M, Luo X and Wang X . (1999). Annu. Rev. Cell Dev. Biol., 15, 269–290.

  • Chandra D, Choy G, Deng X, Bhatia B, Daniel P and Tang DG . (2004). Mol. Cell. Biol., 24, 6592–6607.

  • Cher ML, Biliran Jr HR, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M and Sheng S . (2003). Proc. Natl. Acad. Sci. USA, 100, 7847–7852.

  • Choi KB, Wong F, Harlan JM, Chaudhary PM, Hood L and Karsan A . (1998). J. Biol. Chem., 273, 20185–20188.

  • Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW and Oh YJ . (2004). J. Biol. Chem., 279, 20451–20460.

  • Datta SR, Brunet A and Greenberg ME . (1999). Genes Dev., 13, 2905–2927.

  • Deng Y, Lin Y and Wu X . (2002). Genes Dev., 16, 33–45.

  • Dickinson JL, Norris BJ, Jensen PH and Antalis TM . (1998). Cell. Death Differ., 5, 163–171.

  • Dimmeler S, Breitschopf K, Haendeler J and Zeiher AM . (1999). J. Exp. Med., 189, 1815–1822.

  • Ferrari D, Stepczynska A, Los M, Wesselborg S and Schulze-Osthoff K . (1998). J. Exp. Med., 188, 979–984.

  • Fidler IJ and Ellis LM . (1994). Cell, 79, 185–188.

  • Folkman J . (1986). Cancer Res., 46, 467–473.

  • Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H and Domann FE . (2002). Nat. Genet., 31, 175–179.

  • Gilot D, Loyer P, Corlu A, Glaise D, Lagadic-Gossmann D, Atfi A, Morel F, Ichijo H and Guguen-Guillouzo C . (2002). J. Biol. Chem., 277, 49220–49229.

  • Gurtu V, Kain SR and Zhang G . (1997). Anal. Biochem., 251, 98–102.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Juin P, Hueber AO, Littlewood T and Evan G . (1999). Genes Dev., 13, 1367–1381.

  • LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ and Pribluda VS . (2003). Cancer Res., 63, 468–475.

  • Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD, Lin B, Chen G, Lu J, Lin F, Xie Z, Fontana JA, Reed JC and Zhang X . (2000). Science, 289, 1159–1164.

  • Li H, Zhu H, Xu CJ and Yuan J . (1998). Cell, 94, 491–501.

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X . (1997). Cell, 91, 479–489.

  • Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L and Marcelli M . (2001a). Cancer Res., 61, 1699–1706.

  • Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M and Zhan X . (2001b). Cancer Res., 61, 6906–6911.

  • Liu J, Yin S, Reddy N, Spencer C and Sheng S . (2004). Cancer Res., 64, 1703–1711.

  • Luo X, Budihardjo I, Zou H, Slaughter C and Wang X . (1998). Cell, 94, 481–490.

  • McGettrick AF, Barnes RC and Worrall DM . (2001). Eur. J. Biochem., 268, 5868–5875.

  • Risau W . (1997). Nature, 386, 671–674.

  • Sanchez I, Xu CJ, Juo P, Kakizaka A, Blenis J and Yuan J . (1999). Neuron, 22, 623–633.

  • Sheng S, Pemberton PA and Sager R . (1994). J. Biol. Chem., 269, 30988–30993.

  • Shi HY, Liang R, Templeton NS and Zhang M . (2002). Mol. Ther., 5, 755–761.

  • Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D and Zhang M . (2001). Cancer Res., 61, 6945–6951.

  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ . (1999). J. Cell Biol., 144, 281–292.

  • Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW . (2001). Nature, 409, 207–211.

  • Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H and Whiteside TL . (2000). Br. J. Cancer, 82, 981–989.

  • Tang D, Lahti JM and Kidd VJ . (2000). J. Biol. Chem., 275, 9303–9307.

  • Tewari M and Dixit VM . (1995). J. Biol. Chem., 270, 3255–3260.

  • Tewari M, Beidler DR and Dixit VM . (1995). J. Biol. Chem., 270, 18738–18741.

  • Tuxhorn JA, McAlhany SJ, Yang F, Dang TD and Rowley DR . (2002). Cancer Res., 62, 6021–6025.

  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X . (1997). Science, 275, 1129–1132.

  • Yuan Y, Liao L, Tulis DA and Xu J . (2002). Circulation, 105, 2653–2659.

  • Zhang M, Maass N, Magit D and Sager R . (1997a). Cell Growth Differ., 8, 179–186.

  • Zhang M, Magit D and Sager R . (1997b). Proc. Natl. Acad. Sci. USA, 94, 5673–5678.

  • Zhang M, Shi Y, Magit D, Furth PA and Sager R . (2000a). Oncogene, 19, 6053–6058.

  • Zhang M, Volpert O, Shi YH and Bouck N . (2000b). Nat. Med., 6, 196–199.

  • Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R . (1994). Science, 263, 526–529.

Download references

Acknowledgements

We thank Dr RD Gerard at UT Southwestern Medical School for kindly providing us with the Ad-PAI-1 and Ad-PAI-2, and Dr RJ Youle at NIH for kindly providing us with the Bcl-2-EGFP and Bax-EGFP expression constructs. This study is supported by a NIH Grant CA79736 to MZ.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Z., Shi, H. & Zhang, M. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 24, 2008–2019 (2005). https://doi.org/10.1038/sj.onc.1208449

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208449

Keywords

This article is cited by

Search

Quick links